Close Menu
Home » Thermo Fisher Spent $314M on Two Acquisitions in Q1; Settled IP Suits With Roche 454, Illumina

Thermo Fisher Spent $314M on Two Acquisitions in Q1; Settled IP Suits With Roche 454, Illumina

May 11, 2017
|
staff reporter

NEW YORK (GenomeWeb) – Thermo Fisher Scientific disclosed in a filing yesterday with the US Securities and Exchange Commission the purchase price for its recent acquisitions of Core Informatics and Finesse Solutions, as well as the settlement earlier this year of three patent lawsuits involving DNA sequencing technology from Roche 454 Life Sciences and Illumina.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

One Year On

The University of California, Berkeley's Jennifer Doudna reflects at Science on the anniversary of the announcement of the birth of twin girls who underwent genome editing.

Gigantopithecus' Place in the Family

By studying its enamel proteome, researchers have found the ancient ape Gigantopithecus blacki belongs to a sister clade to that of orangutans.

With BGI There

Bloomberg Businessweek discusses genomics with BGI's Wang Jian.

Science Papers Describe How Gut Microbiome Transplant Affects Neuron Growth, More

In Science this week: researchers find transplanting the gut microbiome in mice affects physiology, and more.

What's Popular?

In Business News

  1. Qiagen Says It Is Fielding Acquisition Offers

  2. Illumina Proposes Opening PacBio IP to Competitors to Save Acquisition Deal

  3. Qiagen Upgraded to Overweight by JP Morgan; Stock Surges on Thermo Fisher Buyout Speculation

  4. In Brief This Week: Invitae, Thermo Fisher, PerkinElmer, More

  5. People in the News: Jessica Mega, Pardis Sabeti, Thomas Caskey, Robert Ford, Miles White, More

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2019 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.